The Aortix™ device is an investigational device that is being evaluated in clinical trials in the United States and Australia.

Enrollment completed

The Aortix CRS Pilot Study (NCT04145635) has completed enrolling patients admitted to the hospital with a primary diagnosis of acute decompensated heart failure.
For more information on the study see

Enrollment ongoing

The Aortix Therapy for Perioperative Reduction of Kidney Injury Study (NCT04999163) is currently enrolling patients in Australia who are undergoing cardiac surgery and at high risk of developing AKI.
For more information on the study see